US OptionsDetailed Quotes
RIGL241220C40000
- 0.04
- 0.000.00%
15min DelayClose Dec 13 11:59 ET
0.00High0.00Low
0.04Open0.04Pre Close0 Volume2 Open Interest40.00Strike Price0.00Turnover298.01%IV111.74%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.0192Delta0.0074Gamma472.75Leverage Ratio-0.0252Theta0.0000Rho9.10Eff Leverage0.0010Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet